Get started

Pennystock

TAAT about to get uplisted on the NASDAQHello bull gang, this one is a short term and I'd keep my expectation low. Intro: TAAT is a hemp cigarettes distributor and on the 26th April, submitted initial application on the NASDAQ which takes max 4 weeks to approve. I've marked 2 possible dates when NASDAQ application will be approved, one is less than 2 weeks and another one is between 2 and 4 weeks. The quicker approved, the less possibility to dip and drop of volume. If after 1-2 weeks it's not approved, expect drop in volume, interest and price. Pros: -Volume rising, can hold for 1-2 weeks -Place for growth, can target 5-6$ price in short term. -Short play, max 4 weeks to approve the application. -Can quick sell the news to other late buyers. -Retail it on the NASDAQ or sell the news on the day of approval. Cons: -Serious red day will send it to dip and kill the trend. -Volume may not survive even one week. -Holding 4 weeks is a risk and you should setup your stop loss trigger in case things turn ugly. -OTC stock, prone to manipulation. Small Warning: Do not take this as financial advise, think before you buy something and plan ahead.
CSE:TAATLong
by DumpItAgain
ZOM hits lows and bounces back hardI will admit if a trade doesn't come to what I think it will do I'll say im wrong, but that's the beauty of tradingview and how we can share ideas. I still remain skeptical of the current price action and have give a range of price movement of the current price. As a trader watching on the sidelines I still believe for a new/long term trade is wait till earnings. This movement up is unknown why its pumping but a few reasons may be the cause Why is this pumping? -Whole market is recovering at this time and biotech/pennystocks are feeling some love which were one of the worst hit sectors. -Past buyers bought the dip and has had an amazing bounce back, which I will talk about in the TA portion. -The sentiment around ZOM was negative people panic sold from $1.15 too .73, which caused the sellers to be exhausted. With no more sellers the price rebounded and fomo struck. TA: Its interesting cause the chart goes aganist the news, so an idea of this is a short squeeze to exit positions. Who knows -April 22, we skyrocketed towards the 50ema and held causing a bullish reversal in the RSI as it held -RSI leads bullish with the current movement of the stock -Resistance is at 1.41, but could say its at 1.18 with past high or go off the emas, which is at 1.13 and 1.29 -Support would be at the 50 ema .97/.96 or slightly before at 1.01 which could be a dip opportunity. -If the trade goes south you could experience a 29%-74% lost with an upside of 124% going back to ath Final thoughts I'll remain skeptical of this pump till er, since again it could be a pump to have people fomo and sell into the buyers or just exhaustion from the months of downward movement. With TA however it remains bullish/neutral
AMEX:ZOM
by nathanielx9
$CLOV can rise in the next daysContextual immersion trading strategy idea. Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $9.67; stop-loss — $8.48. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:CLOVLong
by KozakHlib
8
Catalent Is about to beat earnings?Now I've been watching Catalent, since they partnered up with one of the stocks I hold for a COVID treatment. Novan. Doing a quick glance at CTLT I noticed a TA pattern known as a double bottom and with certain catalyst coming out, maybe its about to run up and leave this bearish trend. News -ER is in 14 days -They have partnered up with Novan to design the injection of Novan's product that can treat/reduce spread of COVID by 90%, which comes out in Q3. TA As you can see the curve lines represents the two bottoms and the top with two white lines pointing at support points. Now note that this could be just a trading zone, yet we will get into the bullish argument. -MACD a cross over is turning bullish -RSI is rising, yet would need to break 52.47. Also if you want, you could say its already bullish on the RSI with a small error margin in TA. -Resistance would be at 110.87, 114.67, and finally the high of 125-127 -Support is at 106.89 and 100.52. -The emas aren't bad with it ending on top of the 50ema which leans bullish in the short term. -VPVR levels are really high at where it closes today with the resistance in the VPVR at 113 and the support at 106-107 Final thoughts It leans bullish if the Double Bottom pattarn plays out and could see it run up nicely on ER. This ER is Q2 for Catalant, so the COVID play will come out sometime after.
NYSE:CTLTLong
by nathanielx9
NOVAN a biotech stock that might fly very soonDisclaimer: I do own a position and you may want to do your own DD, since this post maybe bias even if its not. Please do your own research. Novan is a pennystock biotech that picked up steam last fall like many pennystocks, but through out 2021 stocks have been getting hit with biotech and pennystocks/low caps being the worst hit sectors. Cathie Woods states in her investment strategy is buy sectors that are hurt the most and that have the protentional to move higher. Novan is its own patient product of nitric oxide throughout United States and Europe and wants to expand on it. News -March 29th The CEO bought 70,000 shares, which is bullish when the CEO is buying -Voting has started and results come in on May 4th. There are many things in here such as increasing the share count by 15million, which shares off 200million doesn't seem much. This doesn't mean shares will get dumped it just means they have the option to do offerings in the future. -Q2 (current quater that last till the end of May possibly June) they will get the results of sb206 B, which looks positive. sb206 will the first every treatment for a skin condition called Mollescum. In doing a quick google search, business wire estimates in 2017 there was over 12million cases and half was in the United States. Googling Mollescum cases in the United States go up 200k a year. Now how does Novan fit into this? Well they would be the only FDA treatment on the market, which would send market shares shoring to a billion dollar valution in a short period time (pt would be around $7). -They also partnered up with Catalent to develop a COVID treatment, which has shown with Novan's product that can reduce the spread of Covid of around 90%. Which catalyst would send Novan to a 10billion dollar valuation, but its up to Catalent. This product is suppose to hit in Q3/Q4, but leans more of a Q3. Pipeline -Like ZOM, Novan is also entering the pet care field, but not a device to do testing. On the last webinar investor prestation, they are working to test their product to help skin dieses in dogs and atm are targeting K9s. This would pickup after sb206 and would get more news sometime around q4 or early next year (most likely when they get the marketing of sb206 going). TA: Now that was alot of "shilling," but its great to know the protentional of a mid/long term play of Novan. It begs the question is if the pennystock is under the radar. Zack Investments and a big advocate in Novan and gave Novan a pt of $4, but 2021 hit and crashed the market. So heres some TA that might help you keep your risk at check if you enter. -Resistance in the short term is at $1.08, but closing was $1.10 on April 16, so $1.13 would act more of a challenge. After that is $1.32, $1.45, and then $1.63. With tight consolidation in the past between $1.63-$1.76, breaking that could shoot up to $1.96 or $2+ -Support: support is tricky cause we are free falling like most pennystocks such as ZOM. I would say a micro 5min scale, Every $0.02 is support, but on the hourly we could fall as low $0.96, but its unlikely. Last year we gain compliance of the $1, so there's a lot of buyers from here too $0.96 that will keep it above $1. Now if we get a negative catalyst we could drop too $0.86-$0.81 -MACD leans bearish as we look for a reversal -RSI is oversold and leans bullish for a bounce back with resistance at 46.89. If people wondering where I get these RSI lines, I look at where its uptrending and make a guess where it breaks and the price starts dropping and the RSI goes from overbought to oversold levels. -VPVR means shit like ZOM's TA, but in the past a lot of support at these levels in the past. -Current EMA 50 is at $1.27, 128 is at $1.40, and the 200 is at $1.45. Final Thoughts Biotechs are risky, but with the CEO buying at $1.40 and seeing the price way below that is a sign to toss in some money or go all in. Its up too you, but I would take the bet and wait this storm out. The confidence between ZOM and Novan is I would pick a stock that has a bigger upside in a near term timeline. Again its best too do your own your research.
NLong
by nathanielx9
3
$FRO can fall in the next daysContextual immersion trading strategy idea. Frontline Ltd., a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price in the next days. So I opened a short position from $6,77; stop-loss — $7,10. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NYSE:FROShort
by KozakHlib
2
$OUST can rise in the next daysContextual immersion trading strategy idea. Ouster, Inc. provides high-resolution digital lidar sensors that offer 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $9,87; stop-loss — $8,57. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NYSE:OUSTLong
by KozakHlib
ZOM a love child to novice investorsZOM is interesting since through out the pandemic, people wanted to find ways to make money at home. That's why we had stories from Hertz, DOGE, GME, AMC, and more, but some of these investors found r/PennyStocks. I could list alot of hot names like NNDM, IDEX, XSPA, and more, but we are here to talk about ZOM yet its good to know what kind of investors are in/attractive to a stock like ZOM. Overall I'm a mid term bear, but you could be neutral. News: Now I haven't invested a single penny, yet I like seeing a stock that had an mc over 2billion dollars just to come back to pennystock land of the dead -3 insiders sale publish on Apr 13. -Apr 15: ZOM releases a Investor news on their website stating their distributor failed to help them gain initial sales, so in return they are going to go with a direct sales approach. Also in the letter they couldn't state when they will be profitable. This is a red flag on multiparts. First: they push their own problems on a distributor and not their product. There still hasn't been any demand from the stock price if their product was successful. Second: Changing gears on how to market their device, since launch and haven't tweeted/remain inactive on social media like twitter since Jan 4th is very concerning on if they are still trying to build this company. Third: Profitability. Again we don't know the demand and we don't know if this new marketing strategy will work. This means the company will continue its cash burn and sale shares or dilute share holders until profitability. -Earnings are coming up, but it should be clear they will miss Other News: -ZOM releases their product early causing the swing traders to be off guard and start the "sale the news" -Twitter inactive since Jan 4 -Whole market (besides crypto) has been crashing since the start of this year TA: I know the news section was scary and some things are opinionated, but theres questions that need to be answered -Downtrend line since March 26, but sale off started on March 16. Leans Bearish -Resistance is at 1.00130, 1.4166, and then 2.0075. If the downtrend line holds up .9947 is resistance at open. Leans bearish -EMA continues down with 50 at roughly 1.06. 128 1.36, and 1.49 at the 200. Massive moves are needed, so unlikely to see it hitting there anytime soon. Would need sideways movement or a bounce back. -Support hits .8367, then a massive drop too 0.4413 since between was a gap up. After that its a drop too 0.2802 another unknownzone, but it lighter note could be a buying opportunity 0.2802-04413. This area would be massive pain since if you bought at ath you would be down over 70% and at 0.2802 its at 89% which is prime for a bounce back. Buying from .5-.28 should only be gamble money. -MACD leans bearish -RSI is way oversold with resistance at 51.91 -VPVR levels mean shit atm, but during the rally the last big one I see is at 0.488, so a quick trade from .5 buy in could bounce back to .8-$1 on a trading perspective. Final thoughts Now this stock has had major bearish news and the question is will the earnings help or cause more pain. The answer isn't clear cut, cause as an investor or a speculator we don't know the sales and the quick change in direction on sales cause me to believe in the short term and mid bearish perspective. Now if earnings come out and sales are better than suspected then theres no problems, but watch out if the next days after it continues too sale off.
AMEX:ZOMShort
by nathanielx9
4
$SGRP can rise in the next daysContextual immersion trading strategy idea. SPAR Group, Inc., together with its subsidiaries, provides merchandising and marketing services worldwide. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,91; stop-loss — $1,70. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:SGRPLong
by KozakHlib
$JWEL can rise in the next daysContextual immersion trading strategy idea. Jowell Global Ltd. engages in the online retail of cosmetics, health and nutritional supplements, and household products in China. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $8,20; stop-loss — $7,32. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:JWELLong
by KozakHlib
$GTIM can rise in the next daysContextual immersion trading strategy idea. Good Times Restaurants Inc., through its subsidiaries, engages in the restaurant business in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $4,85; stop-loss — $3,92. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:GTIMLong
by KozakHlib
OCG BIG BUY at 5.70 up to 20.00! COMING SOON!Technical Analysis 1. Forming of Large Pennant/Falling Wedge 2. Expect the market to fall to Fibonacci 0.618 Level which would complete our Pennant/Falling Wedge and the market could potentially reach Over Sold levels on RSI and hitting the support structures 3. Fibonacci Level of 0.786 is also sitting on the Horizontal and Trendline support structure level 4. 2 potential support levels, Horizontal and Trendline (creating area of confluence) 5. Our Take Profit is sitting on the Flagpole Take Profit length, as well as Fibonacci Expansion Safe, Take Profit Zone at Level 1 To MAXIMIZE your profits it's best to buy at 5.70 all the way to 20.00 (I would wait for the market to fall to the new Support level before buying up) Expect to Take Profit sometime in Mid June - August 2021
NASDAQ:OCGLong
by traderprosignals
OCG BIG BUY at 5.70 up to 20.00! COMING SOON!Technical Analysis 1. Forming of Large Pennant/Falling Wedge 2. Expect the market to fall to Fibonacci 0.618 Level which would complete our Pennant/Falling Wedge and the market could potentially reach Over Sold levels on RSI and hitting the support structures 3. Fibonacci Level of 0.786 is also sitting on the Horizontal and Trendline support structure level 4. 2 potential support levels, Horizontal and Trendline (creating area of confluence) 5. Our Take Profit is sitting on the Flagpole Take Profit length, as well as Fibonacci Expansion Safe, Take Profit Zone at Level 1 To MAXIMIZE your profits it's best to buy at 5.70 all the way to 20.00 - I would not consider buying in anytime earlier than this as there is a clear horizontal structure level. The market will and more likely launch off from 5.70
NASDAQ:OCGLong
by traderprosignals
$PAVM can rise in the next daysContextual immersion trading strategy idea. PAVmed Inc . operates as a medical device company in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position again from $4,97; stop-loss — $4,42. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:PAVMLong
by KozakHlib
7
$MOXC entry PTs 4.31-4.45 Target PTs 7.40-9Moxian, Inc. operates a social network platform that integrates social media and business into a single platform in China. The company's products and services focuses on creating interaction between users and merchant clients by allowing merchant clients to study consumer behavior. It serves small and medium sized enterprises. The company was formerly known as Moxian China, Inc. and changed its name to Moxian, Inc. in July 2015. Moxian, Inc. was founded in 2010 and is based in Hong Kong, Hong Kong.
MLong
by UnknownUnicorn19246015
1
MMED about to get a big catalystHello bull gang and bagholders, after long 6 months of bagholding, the NASDAQ uplisting is around the corner. On 3/30/2021, after market, MMED released a news about filing form F-10 with SEC, which will give them the ability to sell securities in USA. Also, on April 12, MMED will uphold a vote and any investor who holds MMED or MMEDF shares will be able to vote, this is obvious that the vote is about NASDAQ uplisting because they cannot uplist our shares on another exchange without our permission. I am in full support to uplist the shares on NASDAQ and once the vote is passed and majority agrees to uplist, it will trigger a catalyst and the price easily can hit 7-10$ on the hype. I also think that on the uplisting day, the shares can go up in price because of retail to Robinhood traders. At last, we finally rise up to the skies. However, please consider risk and do your own DD before buying as this is my own opinion and speculation. Thanks gang.
MLong
by DumpItAgain
1